CCL2 and breast carcinoma: EZH2 depletion leads to the stagnation of M2 TAM polarization (60. Down regulation of CCL2 expression by miR-126 and miR-126* inhibits the recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis (67).